166 related articles for article (PubMed ID: 3774871)
21. Paroxetine versus amitriptyline for treatment of depression associated with rheumatoid arthritis: a randomized, double blind, parallel group study.
Bird H; Broggini M
J Rheumatol; 2000 Dec; 27(12):2791-7. PubMed ID: 11128665
[TBL] [Abstract][Full Text] [Related]
22. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.
Marchesi C; Ceccherininelli A; Rossi A; Maggini C
Pharmacopsychiatry; 1998 Nov; 31(6):216-21. PubMed ID: 9930635
[TBL] [Abstract][Full Text] [Related]
23. Double-blind placebo-controlled trial of amitriptyline among depressed patients in general practice.
Hollyman JA; Freeling P; Paykel ES; Bhat A; Sedgwick P
J R Coll Gen Pract; 1988 Sep; 38(314):393-7. PubMed ID: 3076905
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study.
Altintoprak AE; Zorlu N; Coskunol H; Akdeniz F; Kitapcioglu G
Hum Psychopharmacol; 2008 Jun; 23(4):313-9. PubMed ID: 18327889
[TBL] [Abstract][Full Text] [Related]
25. A double-blind comparison of clovoxamine and amitriptyline in the treatment of depressed outpatients.
Gelenberg AJ; Wojcik JD; Newell C; Lamping DL; Spring B
J Clin Psychopharmacol; 1985 Feb; 5(1):30-4. PubMed ID: 3882774
[TBL] [Abstract][Full Text] [Related]
26. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis.
van Ophoven A; Pokupic S; Heinecke A; Hertle L
J Urol; 2004 Aug; 172(2):533-6. PubMed ID: 15247722
[TBL] [Abstract][Full Text] [Related]
27. [A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression].
Möslinger-Gehmayr R; Zaninelli R; Contu A; Oberhoff C; Gutschow K; Schindler AE; Staab HJ
Zentralbl Gynakol; 2000; 122(4):195-202. PubMed ID: 10795116
[TBL] [Abstract][Full Text] [Related]
28. Double-blind study of the therapeutic efficacy and tolerability of amitriptylinoxide in comparison with amitriptyline.
Tegeler J; Klieser E; Lehmann E; Heinrich K
Pharmacopsychiatry; 1990 Jan; 23(1):45-9. PubMed ID: 2179974
[TBL] [Abstract][Full Text] [Related]
29. A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression.
Kye CH; Waterman GS; Ryan ND; Birmaher B; Williamson DE; Iyengar S; Dachille S
J Am Acad Child Adolesc Psychiatry; 1996 Sep; 35(9):1139-44. PubMed ID: 8824057
[TBL] [Abstract][Full Text] [Related]
30. A double-blind study of minaprine versus amitriptyline in major depression.
Del Zompo M; Bernardi F; Burrai C; Bocchetta A
Neuropsychobiology; 1990-1991; 24(2):79-83. PubMed ID: 2134115
[TBL] [Abstract][Full Text] [Related]
31. [Clinical double blind comparison of diclofensine and placebo in geriatric patients with depressive syndromes].
Jansen W; Brückner GW; Henauer S; Omer LM
Pharmacopsychiatria; 1982 Nov; 15(6):205-9. PubMed ID: 6760217
[TBL] [Abstract][Full Text] [Related]
32. Paroxetine in the treatment of depression--a randomized comparison with amitriptyline.
Laursen AL; Mikkelsen PL; Rasmussen S; le Fèvre Honoré P
Acta Psychiatr Scand; 1985 Mar; 71(3):249-55. PubMed ID: 3157296
[TBL] [Abstract][Full Text] [Related]
33. A double-blind comparison of zimelidine and amitriptyline in depressive out-patients.
Syvälahti E; Salminen J; Lehtinen V
J Int Med Res; 1982; 10(4):250-6. PubMed ID: 6214441
[TBL] [Abstract][Full Text] [Related]
34. Antidepressant effect of femoxetine and desipramine and relationship to the concentration of amine metabolites in cerebrospinal fluid. A double-blind evaluation.
Dahl LE; Lundin L; le Fèvre Honoré P; Dencker SJ
Acta Psychiatr Scand; 1982 Jul; 66(1):9-17. PubMed ID: 6181653
[TBL] [Abstract][Full Text] [Related]
35. A double-blind study of the comparative antidepressant effect of paroxetine and amitriptyline.
Kuhs H; Rudolf GA
Acta Psychiatr Scand Suppl; 1989; 350():145-6. PubMed ID: 2530773
[No Abstract] [Full Text] [Related]
36. Mianserin versus amitriptyline for depression: a double-blind 6-week trial.
Rabkin JG; McGrath PJ; Quitkin FM; Fyer A; Stewart JW; Liebowitz MR; Markowitz J
Neuropsychobiology; 1984; 12(4):224-8. PubMed ID: 6398862
[TBL] [Abstract][Full Text] [Related]
37. Femoxetine in the prophylaxis of migraine--a randomised comparison with placebo.
Zeeberg I; Orholm M; Nielsen JD; Honore PL; Larsen JJ
Acta Neurol Scand; 1981 Dec; 64(6):452-9. PubMed ID: 6753446
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular (ECG and systolic time intervals) and anticholinergic effects of repeated doses of femoxetine--a comparison with amitriptyline and placebo in healthy men.
Warrington SJ; Turner P; Skrumsager BK
Br J Clin Pharmacol; 1989 Mar; 27(3):343-51. PubMed ID: 2719894
[TBL] [Abstract][Full Text] [Related]
39. Double-blind comparative study of paroxetine and amitriptyline in depressed patients of a university psychiatric outpatient clinic (pilot study).
Battegay R; Hager M; Rauchfleisch U
Neuropsychobiology; 1985; 13(1-2):31-7. PubMed ID: 3162108
[TBL] [Abstract][Full Text] [Related]
40. A double-blind evaluation of zimelidine in comparison to placebo and amitriptyline in patients with major depressive disorder.
Claghorn J; Gershon S; Goldstein BJ; Behrnetz S; Bush DF; Huitfeldt B
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):367-82. PubMed ID: 6225150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
